Nalaganje...

In silico discovery of novel Retinoic Acid Receptor agonist structures

BACKGROUND: Several Retinoic Acid Receptors (RAR) agonists have therapeutic activity against a variety of cancer types; however, unacceptable toxicity profiles have hindered the development of drugs. RAR agonists presenting novel structural and chemical features could therefore open new avenues for...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Schapira, Matthieu, Raaka, Bruce M, Samuels, Herbert H, Abagyan, Ruben
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2001
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC32304/
https://ncbi.nlm.nih.gov/pubmed/11405897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6807-1-1
Oznake: Označite
Brez oznak, prvi označite!